Reinaldo Chacón

800 total citations
26 papers, 580 citations indexed

About

Reinaldo Chacón is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Reinaldo Chacón has authored 26 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Reinaldo Chacón's work include Cancer Treatment and Pharmacology (6 papers), BRCA gene mutations in cancer (4 papers) and Breast Cancer Treatment Studies (4 papers). Reinaldo Chacón is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), BRCA gene mutations in cancer (4 papers) and Breast Cancer Treatment Studies (4 papers). Reinaldo Chacón collaborates with scholars based in Argentina and Italy. Reinaldo Chacón's co-authors include Matías Chacón, José Mordoh, Mario Barugel, Éduardo Bruera, María Marcela Barrio, Alicia Bravo, Pedro M. Politi, Fernando Sánchez Loria, Elisa Roca and L. Cedaro and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Breast Cancer Research and Treatment.

In The Last Decade

Reinaldo Chacón

23 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reinaldo Chacón Argentina 13 302 166 151 92 86 26 580
Ritsuto Fujiwaki Japan 17 215 0.7× 357 2.2× 206 1.4× 87 0.9× 90 1.0× 55 834
Satoshi Tsunetoh Japan 15 243 0.8× 280 1.7× 159 1.1× 67 0.7× 68 0.8× 32 715
Samanta Sarti Italy 17 490 1.6× 205 1.2× 209 1.4× 193 2.1× 60 0.7× 46 803
Victoria Wang United States 12 242 0.8× 379 2.3× 155 1.0× 129 1.4× 115 1.3× 44 805
Dalin Li China 15 296 1.0× 210 1.3× 130 0.9× 110 1.2× 211 2.5× 27 650
Wen Wei China 13 262 0.9× 166 1.0× 202 1.3× 111 1.2× 52 0.6× 21 551
Alexander Meisel Switzerland 12 183 0.6× 147 0.9× 88 0.6× 102 1.1× 39 0.5× 27 486
Marco Johannes Battista Germany 18 426 1.4× 245 1.5× 205 1.4× 154 1.7× 148 1.7× 76 998
Megumi Takehara Japan 13 130 0.4× 74 0.4× 103 0.7× 72 0.8× 73 0.8× 31 468

Countries citing papers authored by Reinaldo Chacón

Since Specialization
Citations

This map shows the geographic impact of Reinaldo Chacón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinaldo Chacón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinaldo Chacón more than expected).

Fields of papers citing papers by Reinaldo Chacón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reinaldo Chacón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinaldo Chacón. The network helps show where Reinaldo Chacón may publish in the future.

Co-authorship network of co-authors of Reinaldo Chacón

This figure shows the co-authorship network connecting the top 25 collaborators of Reinaldo Chacón. A scholar is included among the top collaborators of Reinaldo Chacón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reinaldo Chacón. Reinaldo Chacón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Enrico, Diego, Luisina Bruno, Mora Amat, et al.. (2022). CDK4/6 inhibitors outcomes in patients with advanced breast cancer based on HER2-low expression.. Journal of Clinical Oncology. 40(16_suppl). 1056–1056. 9 indexed citations
3.
4.
Nadal, Jorge, et al.. (2019). Cardiotoxicity Alerts during Treatment with Trastuzumab in Breast Cancer at Four-year Follow-up. 87(2). 103–108. 1 indexed citations
5.
Nervo, Adrián, et al.. (2018). Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria. Breast Care. 13(6). 434–438. 7 indexed citations
6.
7.
8.
Solano, Ángela R., Gitana María Aceto, Serena Veschi, et al.. (2012). BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin. SpringerPlus. 1(1). 20–20. 45 indexed citations
9.
Roberti, María P., Yamila Rocca, Mora Amat, et al.. (2012). IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients. Breast Cancer Research and Treatment. 136(3). 659–671. 48 indexed citations
10.
Chacón, Reinaldo, et al.. (2010). Triple-negative breast cancer. Breast Cancer Research. 12(S2). S3–S3. 188 indexed citations
11.
Aceto, Gitana María, Ángela R. Solano, Serena Veschi, et al.. (2009). High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer. Breast Cancer Research and Treatment. 122(3). 671–683. 24 indexed citations
12.
O’Connor, Jacqueline M., et al.. (2008). Adjuvant chemotherapy in soft tissue sarcoma (STS): A meta-analysis of published data. Journal of Clinical Oncology. 26(15_suppl). 10526–10526. 22 indexed citations
13.
Nasroulah, Federico, Juan Manuel O’Connor, Maximiliano Van Kooten, Carlos Tajer, & Reinaldo Chacón. (2007). PD5-2-7: Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: a metaanalysis of randomized phase III trials. Journal of Thoracic Oncology. 2(8). S477–S478. 1 indexed citations
14.
Barrio, María Marcela, et al.. (2006). A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients. Journal of Immunotherapy. 29(4). 444–454. 35 indexed citations
15.
Chacón, Reinaldo, et al.. (2005). Dramatic Responses to Therapy in Rare Tumors. Journal of Clinical Oncology. 23(7). 1579–1580. 12 indexed citations
16.
Chacón, Reinaldo, et al.. (2005). CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide.. Journal of Clinical Oncology. 23(7). 1579–80. 17 indexed citations
17.
Kooten, Maximiliano Van, Moisés Rosenberg, Mauro Orlando, et al.. (2002). Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer. Investigational New Drugs. 20(4). 439–446. 9 indexed citations
18.
Viniegra, María Eugenia Ibarrarán, Marcelo H. Losso, Alfredo Navigante, et al.. (1990). Cardiovascular autonomic function in anthracycline-treated breast cancer patients. Cancer Chemotherapy and Pharmacology. 26(3). 227–231. 23 indexed citations
19.
Machiavelli, M., Alberto Romero, J. Eduardo Pérez, et al.. (1989). Relation between Delay and Survival in 596 Patients with Breast Cancer. Oncology. 46(2). 78–82. 26 indexed citations
20.
Cazap, Eduardo, Roberto Estévez, M. Bruno, et al.. (1988). Phase II Trial of 4′-Epi-Doxorubicin in Locally Advanced or Metastatic Gastric Cancer. Tumori Journal. 74(3). 313–315. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ritsuto Fujiwaki Breakdown of academic impact, for papers by Satoshi Tsunetoh Breakdown of academic impact, for papers by Samanta Sarti Breakdown of academic impact, for papers by Victoria Wang Breakdown of academic impact, for papers by Dalin Li Breakdown of academic impact, for papers by Wen Wei Breakdown of academic impact, for papers by Alexander Meisel Breakdown of academic impact, for papers by Marco Johannes Battista Breakdown of academic impact, for papers by Megumi Takehara
Rankless by CCL
2026